Wahlstrom JL[au] - Search Results

Year	Number of Results
1998	1
2001	1
2002	2
2003	3
2005	1
2006	6
2007	3
2008	4
2009	1
2010	2
2011	3
2012	3
2015	1
2016	1
2020	1
2022	1
2023	0

1

Application of cytochrome P450 drug interaction screening in drug discovery.

Foti RS, Wienkers LC, Wahlstrom JL. Foti RS, et al. Among authors: wahlstrom jl. Comb Chem High Throughput Screen. 2010 Feb;13(2):145-58. doi: 10.2174/138620710790596718. Comb Chem High Throughput Screen. 2010. PMID: 20053168 Review.

2

Prediction of CYP-mediated drug interactions in vivo using in vitro data.

Foti RS, Wahlstrom JL. Foti RS, et al. Among authors: wahlstrom jl. IDrugs. 2008 Dec;11(12):900-5. IDrugs. 2008. PMID: 19051152 Review.

3

Three-dimensional quantitative structure-activity relationship analysis of cytochromes p450: effect of incorporating higher-affinity ligands and potential new applications.

Locuson CW, Wahlstrom JL. Locuson CW, et al. Among authors: wahlstrom jl. Drug Metab Dispos. 2005 Jul;33(7):873-8. doi: 10.1124/dmd.105.004325. Epub 2005 Apr 20. Drug Metab Dispos. 2005. PMID: 15843486 Review.

4

Absorption, Distribution, Metabolism, and Excretion of [¹⁴C]-Sotorasib in Rats and Dogs: Interspecies Differences in Absorption, Protein Conjugation and Metabolism.

Dahal UP, Rock BM, Rodgers J, Shen X, Wang Z, Wahlstrom JL. Dahal UP, et al. Among authors: wahlstrom jl. Drug Metab Dispos. 2022 May;50(5):600-612. doi: 10.1124/dmd.121.000798. Epub 2022 Feb 13. Drug Metab Dispos. 2022. PMID: 35153196

5

Strain-Dependent Variability of Early Discovery Small Molecule Pharmacokinetics in Mice: Does Strain Matter?

Barr JT, Tran TB, Rock BM, Wahlstrom JL, Dahal UP. Barr JT, et al. Among authors: wahlstrom jl. Drug Metab Dispos. 2020 Aug;48(8):613-621. doi: 10.1124/dmd.120.090621. Epub 2020 May 30. Drug Metab Dispos. 2020. PMID: 32474442

6

Ligand-based design of a potent and selective inhibitor of cytochrome P450 2C19.

Foti RS, Rock DA, Han X, Flowers RA, Wienkers LC, Wahlstrom JL. Foti RS, et al. Among authors: wahlstrom jl. J Med Chem. 2012 Feb 9;55(3):1205-14. doi: 10.1021/jm201346g. Epub 2012 Jan 31. J Med Chem. 2012. PMID: 22239545

7

Enzyme source effects on CYP2C9 kinetics and inhibition.

Kumar V, Rock DA, Warren CJ, Tracy TS, Wahlstrom JL. Kumar V, et al. Among authors: wahlstrom jl. Drug Metab Dispos. 2006 Nov;34(11):1903-8. doi: 10.1124/dmd.106.010249. Epub 2006 Aug 23. Drug Metab Dispos. 2006. PMID: 16928789 Free PMC article.

8

In vitro inhibition of multiple cytochrome P450 isoforms by xanthone derivatives from mangosteen extract.

Foti RS, Pearson JT, Rock DA, Wahlstrom JL, Wienkers LC. Foti RS, et al. Among authors: wahlstrom jl. Drug Metab Dispos. 2009 Sep;37(9):1848-55. doi: 10.1124/dmd.109.028043. Epub 2009 Jun 18. Drug Metab Dispos. 2009. PMID: 19541824

9

Advances in predicting CYP-mediated drug interactions in the drug discovery setting.

Wahlstrom JL, Rock DA, Slatter JG, Wienkers LC. Wahlstrom JL, et al. Expert Opin Drug Discov. 2006 Dec;1(7):677-91. doi: 10.1517/17460441.1.7.677. Expert Opin Drug Discov. 2006. PMID: 23495993

10

Mechanism-based inactivation of cytochrome P450 3A4 by mibefradil through heme destruction.

Foti RS, Rock DA, Pearson JT, Wahlstrom JL, Wienkers LC. Foti RS, et al. Among authors: wahlstrom jl. Drug Metab Dispos. 2011 Jul;39(7):1188-95. doi: 10.1124/dmd.111.038505. Epub 2011 Mar 29. Drug Metab Dispos. 2011. PMID: 21447734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results